| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10911046 | Lung Cancer | 2013 | 6 Pages |
Abstract
miRNA signature allows predicting response and is of prognostic value for survival in patients with NSCLC treated with first line cisplatin and vinorelbine.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
T. Berghmans, L. Ameye, L. Willems, M. Paesmans, C. Mascaux, J.J. Lafitte, A.P. Meert, A. Scherpereel, A.B. Cortot, I. CsToth, T. Dernies, L. Toussaint, N. Leclercq, J.P. Sculier,